| Title | Author(s) | Year | View Count |
 | Significance of HBV DNA levels at 12 weeks of telbivudine treatment and the 3 years treatment outcome | Seto, WK; Lai, CL; Fung, J; Wong, DKH; Yuen, JCH; Hung, IFN; Yuen, MF | 2011 | 210 |
 | Entecavir monotherapy is effective in viral suppression after liver transplantation for hepatitis B. | Fung, JYY; Chan, SC; Yuen, RMF; Chok, KSH; Sharr, WW; Fan, ST; Dai, J; Seto, WK; Lo, CM | 2011 | 166 |
| Elevation of ALT fails to predict significant histologic abnormalities in chronic hepatitis B patients. | Seto, WK; Lai, CL; Fung, JYY; Yuen, JCH; Wong, DKH; Yuen, RMF | 2011 | 123 |
| Entecavir monotherapy is effective in viral suppression after liver transplantation for hepatitis B (Abstract) | Fung, JYY; Chan, SC; Yuen, MF; Chok, KSH; Sharr, WW; Fan, ST; Dai, J; Seto, WK; Lo, CM | 2011 | 135 |
| HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma | Wong, DKH; Huang, FY; Poon, RTP; Lai, CL; Fung, JYY; Seto, WK; Hung, IFN; Yuen, RMF | 2010 | 118 |
| Significant changes in liver stiffness measurement using transient elastography in hepatitis B patients - 3 year follow-up study | Fung, J; Lai, CL; Wong, D; Seto, WK; Yuen, MF | 2010 | 133 |
| HBV DNA levels after 12 weeks of telbivudine treatment in chronic hepatitis B predicts long-term outcome | Seto, WK; Lai, CL; Fung, J; Wong, D; Yuen, JCH; Hung, IFN; Yuen, MF | 2010 | 177 |
| Switching to lamivudine in entecavir-treated patients with undetectable HBV DNA - final results at 96 weeks | Fung, J; Lai, CL; Wong, D; Seto, WK; Yuen, MF | 2010 | 201 |
| Combination of baseline HBV DNA and ALT levels with on-treatment HBV DNA response to select HBeAg-positive patients for lamivudine therapy | Fung, JYY; Lai, CL; Seto, WK; Wong, DKH; Yuen, JCH; Yuen, RMF | 2009 | 260 |
| Interim analysis of the natural history of chronic hepatitis C genotype 1 and 6 | Seto, WK; Lai, CL; Fung, JYY; Young, JLP; Yuen, JCH; Wong, DKH; Yuen, RMF | 2008 | 138 |
| Interim Analysis of the Natural History of Chronic Hepatitis C Genotype 1 and 6 | Seto, WK; Lai, CL; Fung, JYY; Young, JLP; Yuen, JCH; Wong, DKH; Yuen, RMF | 2008 | 142 |
| Increase in liver stiffness measurements in severe hepatitis B flares | Fung, JYY; But, D; Hsu, A; Cheng, CTK; Hung, IFN; Seto, WK; Wong, BCY; Lai, CL; Yuen, RMF | 2008 | 134 |
| Long-term beneficial outcome of Chinese asymptomatic patients with HBeAg-positive chronic hepatitis B on continuous lamivudine therapy: 7-year experience. | Yuen, RMF; Seto, WK; Chow, DHF; Tsui, K; Wong, DKH; Chan, P; But, D; Lai, CL | 2005 | 90 |
| Long-term beneficial outcome of Chinese asymptomatic patients with HBeAg-positive chronic hepatitis B on continuous lamivudine therapy: 7-year experience | Yuen, RMF; Seto, WK; Chow, DHF; Tsui, K; Wong, DKH; Chan, P; But, D; Lai, CL | 2005 | 89 |
|
